Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al

  1. February 13, 2024

    Mallinckrodt Guts IP Suit Amid Oxide Rival's New Drug App

    A Delaware federal judge has dismissed 10 of the originally asserted 14 patents in pharmaceutical company Mallinckrodt's claims against a French industrial gas company over a generic version of its pediatric breathing disorder treatment, as Mallinckrodt filed an amended complaint adding two additional patents to the suit.

  2. January 03, 2023

    Mallinckrodt Tries To Stop Another Oxide Rival

    Pharmaceutical company Mallinckrodt is going to court to try to stop a French industrial gas company from marketing nitric oxide that would compete with the Inomax brand of oxide that Mallinckrodt has been selling to children with breathing disorders since 1999.